Loading…
Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer
Introduction: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer. Methods: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping...
Saved in:
Published in: | Technology in cancer research & treatment 2020, Vol.19, p.1533033820943244-1533033820943244 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923 |
---|---|
cites | cdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923 |
container_end_page | 1533033820943244 |
container_issue | |
container_start_page | 1533033820943244 |
container_title | Technology in cancer research & treatment |
container_volume | 19 |
creator | Yang, Gang Yang, Yuxia Ma, Xin Huang, Lijun Li, Wenbin Song, Xuejuan Zhang, Huiqin Liu, Wenwen Lu, Juanjuan |
description | Introduction:
To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer.
Methods:
A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology.
Results:
There were no significant differences in gender and drinking among the 3 groups (P > .05). There were significant differences among the 3 groups in both age-group ≤60 and >60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P > .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA.
Conclusion:
Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer. |
doi_str_mv | 10.1177/1533033820943244 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0bc18e2090a34f7f874869168afd967f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1533033820943244</sage_id><doaj_id>oai_doaj_org_article_0bc18e2090a34f7f874869168afd967f</doaj_id><sourcerecordid>2435531607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</originalsourceid><addsrcrecordid>eNp1kdtrFDEUxoMo9qLvPknAF1-m5n55EcrQ1paFFlF8DJlMsptlZrIms4X-92bdutqCTwlfvvM7J-cD4B1GZxhL-QlzShGliiDNKGHsBTjeSc1Oe3m4M3EETkpZI0SEoPg1OKJEYcKRPgY356UkF-0c0wRTgBdf25bDKz_5OTp4l4aHMeXNKpaxwB9xXsE25rxKJRZopx4u4r3PsLWT8_kNeBXsUPzbx_MUfL-8-NZ-aRa3V9ft-aJxnKi5CX2PGWKKYqocY0GToFVQQfcOBcWYZQIToQkPQXW-k07pnlvOsXSk45rQU3C95_bJrs0mx9HmB5NsNL-FlJfG5jr94A3qHFa-bgdZyoIMSjIlNBbKhl4LGSrr85612Xaj752f5myHJ9CnL1NcmWW6N5IxJAmugI-PgJx-bn2ZzRiL88NgJ5-2xRBGOadYIFmtH55Z12mbp7oqQ7hENR3FWXWhvcvlVEr24TAMRmYXunkeei15_-8nDgV_Uq6GZm8odun_dv0v8BcIcrHO</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570002854</pqid></control><display><type>article</type><title>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</title><source>Open Access: PubMed Central</source><source>SAGE Open Access</source><source>Publicly Available Content (ProQuest)</source><creator>Yang, Gang ; Yang, Yuxia ; Ma, Xin ; Huang, Lijun ; Li, Wenbin ; Song, Xuejuan ; Zhang, Huiqin ; Liu, Wenwen ; Lu, Juanjuan</creator><creatorcontrib>Yang, Gang ; Yang, Yuxia ; Ma, Xin ; Huang, Lijun ; Li, Wenbin ; Song, Xuejuan ; Zhang, Huiqin ; Liu, Wenwen ; Lu, Juanjuan</creatorcontrib><description>Introduction:
To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer.
Methods:
A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology.
Results:
There were no significant differences in gender and drinking among the 3 groups (P > .05). There were significant differences among the 3 groups in both age-group ≤60 and >60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P > .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA.
Conclusion:
Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer.</description><identifier>ISSN: 1533-0346</identifier><identifier>EISSN: 1533-0338</identifier><identifier>DOI: 10.1177/1533033820943244</identifier><identifier>PMID: 32812509</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Age ; Cirrhosis ; Gene polymorphism ; Genotype & phenotype ; Genotyping ; Liver cancer ; Liver cirrhosis ; Original</subject><ispartof>Technology in cancer research & treatment, 2020, Vol.19, p.1533033820943244-1533033820943244</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020 2020 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</citedby><cites>FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</cites><orcidid>0000-0001-8446-6382</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440721/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2570002854?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,4012,21953,25740,27840,27910,27911,27912,36999,37000,44577,44932,45320,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32812509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Gang</creatorcontrib><creatorcontrib>Yang, Yuxia</creatorcontrib><creatorcontrib>Ma, Xin</creatorcontrib><creatorcontrib>Huang, Lijun</creatorcontrib><creatorcontrib>Li, Wenbin</creatorcontrib><creatorcontrib>Song, Xuejuan</creatorcontrib><creatorcontrib>Zhang, Huiqin</creatorcontrib><creatorcontrib>Liu, Wenwen</creatorcontrib><creatorcontrib>Lu, Juanjuan</creatorcontrib><title>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</title><title>Technology in cancer research & treatment</title><addtitle>Technol Cancer Res Treat</addtitle><description>Introduction:
To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer.
Methods:
A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology.
Results:
There were no significant differences in gender and drinking among the 3 groups (P > .05). There were significant differences among the 3 groups in both age-group ≤60 and >60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P > .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA.
Conclusion:
Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer.</description><subject>Age</subject><subject>Cirrhosis</subject><subject>Gene polymorphism</subject><subject>Genotype & phenotype</subject><subject>Genotyping</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Original</subject><issn>1533-0346</issn><issn>1533-0338</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kdtrFDEUxoMo9qLvPknAF1-m5n55EcrQ1paFFlF8DJlMsptlZrIms4X-92bdutqCTwlfvvM7J-cD4B1GZxhL-QlzShGliiDNKGHsBTjeSc1Oe3m4M3EETkpZI0SEoPg1OKJEYcKRPgY356UkF-0c0wRTgBdf25bDKz_5OTp4l4aHMeXNKpaxwB9xXsE25rxKJRZopx4u4r3PsLWT8_kNeBXsUPzbx_MUfL-8-NZ-aRa3V9ft-aJxnKi5CX2PGWKKYqocY0GToFVQQfcOBcWYZQIToQkPQXW-k07pnlvOsXSk45rQU3C95_bJrs0mx9HmB5NsNL-FlJfG5jr94A3qHFa-bgdZyoIMSjIlNBbKhl4LGSrr85612Xaj752f5myHJ9CnL1NcmWW6N5IxJAmugI-PgJx-bn2ZzRiL88NgJ5-2xRBGOadYIFmtH55Z12mbp7oqQ7hENR3FWXWhvcvlVEr24TAMRmYXunkeei15_-8nDgV_Uq6GZm8odun_dv0v8BcIcrHO</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Yang, Gang</creator><creator>Yang, Yuxia</creator><creator>Ma, Xin</creator><creator>Huang, Lijun</creator><creator>Li, Wenbin</creator><creator>Song, Xuejuan</creator><creator>Zhang, Huiqin</creator><creator>Liu, Wenwen</creator><creator>Lu, Juanjuan</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8446-6382</orcidid></search><sort><creationdate>2020</creationdate><title>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</title><author>Yang, Gang ; Yang, Yuxia ; Ma, Xin ; Huang, Lijun ; Li, Wenbin ; Song, Xuejuan ; Zhang, Huiqin ; Liu, Wenwen ; Lu, Juanjuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Cirrhosis</topic><topic>Gene polymorphism</topic><topic>Genotype & phenotype</topic><topic>Genotyping</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Gang</creatorcontrib><creatorcontrib>Yang, Yuxia</creatorcontrib><creatorcontrib>Ma, Xin</creatorcontrib><creatorcontrib>Huang, Lijun</creatorcontrib><creatorcontrib>Li, Wenbin</creatorcontrib><creatorcontrib>Song, Xuejuan</creatorcontrib><creatorcontrib>Zhang, Huiqin</creatorcontrib><creatorcontrib>Liu, Wenwen</creatorcontrib><creatorcontrib>Lu, Juanjuan</creatorcontrib><collection>SAGE Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Technology in cancer research & treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Gang</au><au>Yang, Yuxia</au><au>Ma, Xin</au><au>Huang, Lijun</au><au>Li, Wenbin</au><au>Song, Xuejuan</au><au>Zhang, Huiqin</au><au>Liu, Wenwen</au><au>Lu, Juanjuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</atitle><jtitle>Technology in cancer research & treatment</jtitle><addtitle>Technol Cancer Res Treat</addtitle><date>2020</date><risdate>2020</risdate><volume>19</volume><spage>1533033820943244</spage><epage>1533033820943244</epage><pages>1533033820943244-1533033820943244</pages><issn>1533-0346</issn><eissn>1533-0338</eissn><abstract>Introduction:
To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer.
Methods:
A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology.
Results:
There were no significant differences in gender and drinking among the 3 groups (P > .05). There were significant differences among the 3 groups in both age-group ≤60 and >60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P > .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA.
Conclusion:
Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>32812509</pmid><doi>10.1177/1533033820943244</doi><orcidid>https://orcid.org/0000-0001-8446-6382</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1533-0346 |
ispartof | Technology in cancer research & treatment, 2020, Vol.19, p.1533033820943244-1533033820943244 |
issn | 1533-0346 1533-0338 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_0bc18e2090a34f7f874869168afd967f |
source | Open Access: PubMed Central; SAGE Open Access; Publicly Available Content (ProQuest) |
subjects | Age Cirrhosis Gene polymorphism Genotype & phenotype Genotyping Liver cancer Liver cirrhosis Original |
title | Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T04%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20ERCC5%20Genetic%20Polymorphisms%20With%20Cirrhosis%20and%20Liver%20Cancer&rft.jtitle=Technology%20in%20cancer%20research%20&%20treatment&rft.au=Yang,%20Gang&rft.date=2020&rft.volume=19&rft.spage=1533033820943244&rft.epage=1533033820943244&rft.pages=1533033820943244-1533033820943244&rft.issn=1533-0346&rft.eissn=1533-0338&rft_id=info:doi/10.1177/1533033820943244&rft_dat=%3Cproquest_doaj_%3E2435531607%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2570002854&rft_id=info:pmid/32812509&rft_sage_id=10.1177_1533033820943244&rfr_iscdi=true |